FDA Approved Medical Products for:

Fabry disease

The table(s) below may not be an exhaustive list of drugs or products used to treat this condition. There may be other products available that are not considered orphan products.

Generic Name Ceramide trihexosidase/alpha-galactosidase A
Trade Name
(Manufacturer Name)
Fabrazyme®
(Genzyme Corporation)
Indication
The FDA has approved this product to be used in this manner.
For use in patients with Fabry disease to reduce globotriaosylceramide (GL-3) deposition in capillary endothelium of the kidney and certain other cell types
More Information about this product Drug Information Portal